TC Biopharm (Holdings) Plc

NASDAQ (USD): TC Biopharm (Holdings) Plc (TCBP)

Last Price

0.529

Today's Change

-0.055 (9.41%)

Day's Change

0.49 - 0.60

Trading Volume

327,667

Overview

Market Cap

13,080

Shares Outstanding

494,513

Avg Volume

1,167,988

Avg Price (50 Days)

2.11

Avg Price (200 Days)

8.08

PE Ratio

0.00

EPS

-296.15

Earnings Announcement

26-Feb-2025

Previous Close

0.58

Open

0.60

Day's Range

0.4901 - 0.6

Year Range

0.436 - 41.5

Trading Volume

329,924

Price Change Highlight

1 Day Change

-9.40%

5 Day Change

-18.62%

1 Month Change

-18.47%

3 Month Change

-91.94%

6 Month Change

-94.91%

Ytd Change

-98.31%

1 Year Change

-98.22%

3 Year Change

-100.00%

5 Year Change

-100.00%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment